Literature DB >> 192668

Cholera toxin, ganglioside receptors and the immune response.

J Holmgren, L Lindholm.   

Abstract

Cholera toxin activates plasma membrane adenylate cyclase in all mammalian cell types. The structure-function relationship of the toxin has recently been clarified, and the cell membrane receptor identified. This information has made cholera toxin the "agent of choice" for studies in many biological systems of the possible regulatory role of adenylate cyclase/cyclic AMP. This article describes briefly our current knowledge about the toxin and its receptor. It then reviews recent research which has revealed that cholera toxin has strong modulating influences on the proliferation of normal and malignant lympocytes as well as on the initiation and expression of immune responses. The toxin has been found to inhibit DNA synthesis of B and T lymphocytes in vitro without inducing cell death and also to inhibit seems to decrease antibody secretion from plasma cells in vitro, and might also interfere with the release of other soluble immunological mediator subtances. In vivo cholera toxin induces a transient involution of the spleen and a more prolonged lymphocyte depletion of the thymus in mice; these effects appear to be mediated through the adrenal glands. The toxin inhibitors allograft rejection, and either stimulates or suppresses antibody formation depending on the timing of the toxin in relation to the antigen administration. It increases the capacity of the spleen cells to induce graft-vs-host reactions and the "allogeneic effect" on antibody production. An inhibitory effect on a normal suppressor population among the spleen cells has been identified. The findings illustrate the complex effects induced on the immune system by the probably most discriminative investigative tool available for stimulation of the adenylate cyclase/cyclic AMP system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 192668     DOI: 10.3109/08820137609047617

Source DB:  PubMed          Journal:  Immunol Commun        ISSN: 0090-0877


  8 in total

1.  Effect of cholera toxin on the antiviral and anticellular activities of human leukocyte interferon.

Authors:  A Fuse; T Kuwata
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

2.  Cholera toxin-induced tolerance to allografts in mice.

Authors:  S Tsuru; M Taniguchi; N Shinomiya; H Fujisawa; Y Zinnaka; K Nomoto
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

Review 3.  Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells.

Authors:  K L Richards; S D Douglas
Journal:  Microbiol Rev       Date:  1978-09

4.  Mechanism of action of choleragen and E. coli heat-labile enterotoxin: activation of adenylate cyclase by ADP-ribosylation.

Authors:  J Moss; M Vaughan
Journal:  Mol Cell Biochem       Date:  1981-07-07       Impact factor: 3.396

5.  Intestinal immune response to cholera toxin: dependence on route and dosage of antigen for priming and boosting.

Authors:  A M Svennerholm; S Lange; J Holmgren
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

6.  Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

Authors:  N Lycke; J Holmgren
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

7.  Involvement of gangliosides in lymphocyte stimulation.

Authors:  S Spiegel; A Ravid; M Wilchek
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats.

Authors:  N F Pierce
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.